Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
| PHARMANIAGA BERHAD |
Particulars of substantial Securities Holder
| Name | JAKEL MEDICAL SDN BHD |
| Address |
NO. 31-1, JALAN TASIK SELATAN 3 METRO CENTRE
KUALA LUMPUR 57000 Wilayah Persekutuan Malaysia. |
| Company No. | 202501019786 (1621199-T) |
| Nationality/Country of incorporation | Malaysia |
| Descriptions (Class) | Ordinary Shares |
Details of changes
| No | Date of change | No of securities |
Type of Transaction | Nature of Interest |
| 24 Dec 2025 | 96,700,000 |
Acquired | Direct Interest | |
| Name of registered holder | JAKEL MEDICAL SDN BHD | |||
| Address of registered holder | NO. 31-1, JALAN TASIK SELATAN 3, METRO CENTRE, 57000 KUALA LUMPUR | |||
| Description of "Others" Type of Transaction | ||||
| Circumstances by reason of which change has occurred | Acquisition of Shares |
| Nature of interest | Direct Interest |
| Direct (units) | 96,700,000 |
| Direct (%) | 12.093 |
| Indirect/deemed interest (units) | |
| Indirect/deemed interest (%) | |
| Total no of securities after change | 792,945,000 |
| Date of notice | 29 Dec 2025 |
| Date notice received by Listed Issuer | 29 Dec 2025 |
Announcement Info
| Company Name | PHARMANIAGA BERHAD |
| Stock Name | PHARMA |
| Date Announced | 29 Dec 2025 |
| Category | Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016 |
| Reference Number | CS2-29122025-00133 |